100 Clinical Results associated with MSD LLC (Texas)
0 Patents (Medical) associated with MSD LLC (Texas)
01 Jan 2018·[Nihon koshu eisei zasshi] Japanese journal of public health
[A nationwide survey of PPSV23 vaccine coverage rates and their related factors among the elderly in Japan, 2016].
Article
Author: Akira Watanabe ; Mari Oba ; Shin-Ichi Kanazu ; Yoshitaka Murakami ; Yuuji Nishiwaki
01 Jan 2017·Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Pharmacological action and clinical results of Omarigliptin (MARIZEV<sup>®</sup> tablet), a novel dipeptidyl peptidase-4 inhibitor for once-weekly treatment of Type 2 diabetes
Review
Author: Yuka Ito ; Taro Okamoto ; Masahiko Mori ; Yuki Matsumoto
01 Jan 2017·Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Preclinical and clinical properties of elbasvir (ERELSA<sup>®</sup> Tablets 50 mg) and Grazoprevir (GRAZYNA<sup>®</sup> Tablets 50 mg), novel therapeutic agents for hepatitis C
Article
Author: Asante-Appiah, Ernest ; Iwasa, Takashi ; Kinoshita, Kiyoshi ; Nakamura, Keisuke
This paper presents the preclin. and clin. properties of elbasvir and grazoprevir in novel therapeutic agents for hepatitis-C.The paper describes the combination therapy that is effective in a wide range of hepatitis C chronically infected patients with a history of treatment.The therapy has a high antiviral effect even in resistant mutation cases.
100 Deals associated with MSD LLC (Texas)
100 Translational Medicine associated with MSD LLC (Texas)